心不全治療のiPS製品「リハート」、9月に保険適用　5320万円：朝日新聞

Another iPS Product Approved for Public Insurance Coverage in Japan

Tokyo, July 22 (Jiji Press)--The Japanese Central Social Insurance Medical Council, which advises the health minister, on Wednesday approved the application of public health insurance to RiHeart, a cardiac muscle cell…